Hardman Co - Hardman Co Healthcare Index: 2021 – COVID-19 continued to benefit sector

Report

Hardman & Co

Martin Hall

Hardman & Co Healthcare Index: 2021 – COVID-19 continued to benefit sector

The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. Following an exceptional performance in 2020, when investors showed greater appreciation of science as a result of the COVID-19 pandemic, 2021 was a year of reflection. The HHI still increased 12.0%, to 661.5, which was substantially better than the performance of the FTSE AIM All-Share Index (+5.2%), but was modestly below outcomes for the FTSE 100 (+14.3%) and FTSE All-Share (+14.5%) indices. After several spectacular share price performances by companies involved in the challenges posed by the pandemic in 2020, uncertainty over the longevity of COVID-19 resulted in some underperformance of those same stocks in 2021. Also, after a busy year in 2020, when 27 companies took the opportunity to raise more capital, only 10 companies in our universe raised new capital in 2021. At the time of writing, COVID-19 is rearing its ugly head again, suggesting that the life sciences industry will remain a focus of attention in 2022.

10/01/2022 1 EN

Provider

Hardman & Co

We are a rapidly growing, innovative corporate research & consultancy business, based in London, serving the needs of both public and private companies.

Our expert team of sector analysts and market professionals collectively have over 400 years of experience. This depth of knowledge and a reputation for integrity have built trust with investors. With effective communication and precision distribution, we help companies disseminate their investment message to interested investors, as well as advise them on strategy.

Our smaller, boutique structure allows us to provide first-class customer service and to deliver a wide range of ad-hoc services for multiple clients with different needs.

See profile

Analysts

Martin Hall

Other Reports from Hardman & Co

Mark Thomas

Mark Thomas

ICG Enterprise Trust plc (ICGT): Investing in resilience, delivering growth

The key message from ICGT’s FY’25 results (to January) is the continued strength of the operating companies, which delivered, on average, 15% LTM EBITDA growth. Margins have widened by ca.4% (average revenue growth 11%), which should help allay some concerns over the impact of the challenging environment. New investment is accelerating, and realisation activity continued with an average 19% uplift to carrying values on exit. A degree of short-term volatility is to be expected, and the five- and 10-year total annualised NAV per share return (14.5% and 13.8%, respectively) are a good reflection ...

May 21, 2025 May 21, 2025 1 EN

Mark Thomas ... (+2)

Mark Thomas
Mike Foster

Real Estate Credit Investments (RECI): Meeting any potential macro challenges head on

In our view, there remains great uncertainty over the effects of tariffs and whether the US/global economies will fall into a recession. Over the past six years, we have written many times on RECI’s resilient model. In this note, we revisit why RECI’s model is so strong, noting in particular i) its credit assessment, monitoring and problem account management, ii) the benefit of being a senior finance provider, iii) geographical and sector diversity, iv) portfolio mix changes, including the reduction in MTM bond holdings. As noted in previous reports, in challenging macro times, spreads widen, ...

May 20, 2025 May 20, 2025 1 EN

Richard Jeans

Richard Jeans

accesso Technology Group: 30 new venue contracts and pipeline remains strong

FY24 results, released last month, were in line with its January trading update. Revenues grew by 5.3%, when excluding discontinued components, while cash EBITDA eased by 3.4% to $22.8m to reflect a margin of 15.0%. Management is cautious on the near-term outlook due to uncertainties over the impact of trade wars on consumer sentiment. We have cut our revenue forecasts by 4% in FY25 and 6% in FY26 to reflect this uncertainty. However, costs also fall and FY26 adjusted EPS moves higher in USD terms. In spite of the opportunities, the shares trade on a modest 12x our FY27E earnings, supported b...

May 16, 2025 May 16, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Hardman & Co Healthcare Index: 2021 – COVID-19 continued to benefit sector

ICG Enterprise Trust plc (ICGT): Investing in resilience, delivering growth

Real Estate Credit Investments (RECI): Meeting any potential macro challenges head on

accesso Technology Group: 30 new venue contracts and pipeline remains strong

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe